The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification.
Maurizio ColecchiaAlessia BertolottiBiagio PaoliniFrancesca GiunchiAndrea NecchiAnna M PaganoniCostantino RicciMichelangelo FiorentinoGian P DagradaPublished in: Histopathology (2020)
We provide a new tool, the LeSS, for the prediction of malignant behaviour in LCTs.